phenylalanine has been researched along with Cancer of Pancreas in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (16.67) | 18.7374 |
| 1990's | 6 (20.00) | 18.2507 |
| 2000's | 13 (43.33) | 29.6817 |
| 2010's | 5 (16.67) | 24.3611 |
| 2020's | 1 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, M; Hatazawa, J; Horitsugi, G; Ikeda, H; Kanai, Y; Kongpracha, P; Nagamori, S; Naka, S; Shimosegawa, E; Watabe, T | 1 |
| Inohara, H; Jin, C; Kanai, Y; Liu, X; Miyabe, J; Nagamori, S; Ohgaki, R; Ohki, H; Okuda, S; Quan, L; Saito, K; Wei, L; Yoshino, K | 1 |
| Dejong, CHC; den Dulk, M; Grabsch, HI; Horstman, AMH; Olde Damink, SWM; Rensen, SS; Smeets, JSJ; van Dijk, DPJ; van Loon, LJC | 1 |
| Castaño, JP; de Herder, WW; Dogan-Oruc, F; Feelders, RA; Herrera-Martínez, AD; Hofland, LJ; Van den Dungen, R; van Koetsveld, PM | 1 |
| Padmanabhan, J; Woods, NK | 1 |
| Gouverneur, E; Hellwig, D; Kirsch, CM; Menges, M; Raedle, J; Samnick, S; Schaefer, A | 1 |
| Chan, L; Dahl, R; Fiji, HD; Kwon, O; Lu, J; Tamanoi, F | 1 |
| Preston, T; Small, AC | 1 |
| Herse, B; Mirzaie, M; Oster, O; Schöndube, F | 1 |
| Buhr, HJ; Foitzik, T; Hines, OJ; Hotz, B; Hotz, HG; Reber, HA | 1 |
| Bergers, G; Hanahan, D | 1 |
| Barber, MD; Fearon, KC; McMillan, DC; Preston, T; Ross, JA; Slater, C | 2 |
| Amon, M; Feiden, W; Hellwig, D; Kirsch, CM; Kubuschok, B; Menger, MD; Romeike, BF; Samnick, S | 1 |
| Hellwig, D; Kirsch, CM; Menger, MD; Menges, M; Moellers, MO; Romeike, BF; Samnick, S; Schneider, G | 1 |
| Armstrong, C; Durkin, AJ; Osborne, DA; Rosemurgy, AS; Yeatman, TJ; Zervos, EE | 1 |
| Franz, MG; Gower, WR; Norman, JG; Rosemurgy, AS; Zervos, EE | 1 |
| McCann, PP; Rasmussen, HS | 1 |
| Rosemurgy, AS; Shafii, AE; Zervos, EE | 1 |
| Barazzoni, R; Tessari, P; Tiengo, A; Zanetti, M | 1 |
| Bergers, G; Folkman, J; Hanahan, D; Javaherian, K; Lo, KM | 1 |
| Haq, M; Rosemurgy, AS; Shafii, AE; Zervos, EE | 1 |
| Antoniu, BA; Compton, CC; Fernández-Del Castillo, C; Hartwig, W; Jimenez, RE; Warshaw, AL | 1 |
| Haq, M; Rosemurgy, AS; Shafii, A; Zervos, EE | 1 |
| Chiba, T; Itoh, Y; Kajita, M; Kinoh, H; Mori, H; Okada, A; Seiki, M | 1 |
| Dingjan, PG; Postma, T; Stroes, JA | 1 |
| Cha, CM; Cha, S; Mastrofrancesco, B; Randall, HT | 1 |
| Barreto, M; Malaisse, WJ; Sener, A; Valverde, I | 1 |
| Hine, P; Kay, G; Timperley, WR; Warnes, TW | 1 |
| Karuzina, NP; Timofeevskaia, EA | 1 |
1 review(s) available for phenylalanine and Cancer of Pancreas
| Article | Year |
|---|---|
Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Colorectal Neoplasms; Enzyme Inhibitors; Female; Hemangioma; Humans; Hydroxamic Acids; Melanoma; Metalloendopeptidases; Mice; Ovarian Neoplasms; Pancreatic Neoplasms; Phenylalanine; Protease Inhibitors; Skin Neoplasms; Thiophenes | 1997 |
2 trial(s) available for phenylalanine and Cancer of Pancreas
| Article | Year |
|---|---|
Modulation of the liver export protein synthetic response to feeding by an n-3 fatty-acid-enriched nutritional supplement is associated with anabolism in cachectic cancer patients.
Topics: Aged; Albumins; Cachexia; Chi-Square Distribution; Dietary Supplements; Fasting; Fatty Acids, Omega-3; Female; Fibrinogen; Humans; Liver; Male; Middle Aged; Nitrogen; Pancreatic Neoplasms; Phenylalanine; Statistics, Nonparametric | 2004 |
Liver export protein synthetic rates are increased by oral meal feeding in weight-losing cancer patients.
Topics: Adult; Albumins; Eating; Female; Fibrinogen; Hormones; Humans; Kinetics; Liver; Male; Middle Aged; Pancreatic Neoplasms; Phenylalanine; Protein Biosynthesis; Ultrafiltration; Weight Loss | 2000 |
27 other study(ies) available for phenylalanine and Cancer of Pancreas
| Article | Year |
|---|---|
Distribution of LAT1-targeting PET tracer was independent of the tumor blood flow in rat xenograft models of C6 glioma and MIA PaCa-2.
Topics: Animals; Blood Circulation; Boron Compounds; Cell Line, Tumor; Cell Transformation, Neoplastic; Glioma; Humans; Large Neutral Amino Acid-Transporter 1; Male; Pancreatic Neoplasms; Phenylalanine; Positron-Emission Tomography; Radioactive Tracers; Radiopharmaceuticals; Rats; Tissue Distribution; Tyrosine | 2019 |
Boron delivery for boron neutron capture therapy targeting a cancer-upregulated oligopeptide transporter.
Topics: Animals; Biological Transport; Boron Compounds; Boron Neutron Capture Therapy; Cell Line, Tumor; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Peptide Transporter 1; Phenylalanine; Symporters; Tyrosine; Up-Regulation; Xenograft Model Antitumor Assays | 2019 |
Tumour-specific and organ-specific protein synthesis rates in patients with pancreatic cancer.
Topics: Aged; Biopsy; Carbon Isotopes; Female; Humans; Liver; Male; Middle Aged; Muscle, Skeletal; Pancreas; Pancreatic Neoplasms; Pancreaticoduodenectomy; Phenylalanine; Protein Biosynthesis | 2019 |
Effect of the Tryptophan Hydroxylase Inhibitor Telotristat on Growth and Serotonin Secretion in 2D and 3D Cultured Pancreatic Neuroendocrine Tumor Cells.
Topics: Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; In Vitro Techniques; Neuroendocrine Tumors; Pancreatic Neoplasms; Phenylalanine; Pyrimidines; Serotonin; Tryptophan Hydroxylase; Tumor Cells, Cultured | 2020 |
Inhibition of amyloid precursor protein processing enhances gemcitabine-mediated cytotoxicity in pancreatic cancer cells.
Topics: ADAM Proteins; ADAM10 Protein; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Proliferation; Cytotoxins; Deoxycytidine; Dipeptides; Gemcitabine; Humans; Hydroxamic Acids; Membrane Proteins; Neoplasm Proteins; Pancreatic Neoplasms; Phenylalanine; Protease Inhibitors; Protein Structure, Tertiary; Thiophenes | 2013 |
Para-[(123)I]iodo-L-phenylalanine in patients with pancreatic adenocarcinoma: tumour uptake, whole-body kinetics, dosimetry.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Female; Half-Life; Humans; Iodine Radioisotopes; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Pancreatic Neoplasms; Phenylalanine; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Whole-Body Irradiation | 2008 |
In vivo antitumor effect of a novel inhibitor of protein geranylgeranyltransferase-I.
Topics: Alkyl and Aryl Transferases; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Enzyme Inhibitors; Female; Humans; Mice; Mice, SCID; Pancreatic Neoplasms; Phenylalanine; Protein Prenylation; Sulfonamides; Xenograft Model Antitumor Assays | 2009 |
Improved measurement of protein synthesis in human subjects using 2H-phenylalanine isotopomers and gas chromatography/mass spectrometry.
Topics: Albumins; Amino Acids; Deuterium; Esters; Fluorocarbons; Gas Chromatography-Mass Spectrometry; Humans; Isotope Labeling; Organosilicon Compounds; Pancreatic Neoplasms; Phenylalanine; Protein Biosynthesis; Proteins | 2010 |
The matrix metalloproteinase inhibitor batimastat inhibits the lung colonisation of orthotopically implanted malignant pancreatic tumor cells in SCID mice.
Topics: Animals; Antineoplastic Agents; Drug Evaluation; Injections, Intraperitoneal; Lung; Lung Neoplasms; Matrix Metalloproteinase Inhibitors; Mice; Mice, SCID; Neoplasm Transplantation; Pancreas; Pancreatic Neoplasms; Phenylalanine; Protease Inhibitors; Thiophenes; Tumor Cells, Cultured | 2002 |
Evaluation of vascular endothelial growth factor blockade and matrix metalloproteinase inhibition as a combination therapy for experimental human pancreatic cancer.
Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Chi-Square Distribution; Disease Models, Animal; Drug Therapy, Combination; Endothelial Growth Factors; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Male; Matrix Metalloproteinases; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Pancreatic Neoplasms; Phenylalanine; Probability; Reference Values; Sensitivity and Specificity; Statistics, Nonparametric; Thiophenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Combining antiangiogenic agents with metronomic chemotherapy enhances efficacy against late-stage pancreatic islet carcinomas in mice.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Carcinoma, Islet Cell; Chronotherapy; Indoles; Matrix Metalloproteinase Inhibitors; Mice; Neovascularization, Pathologic; Pancreatic Neoplasms; Phenylalanine; Protease Inhibitors; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Thiophenes | 2002 |
p-[123I]iodo-L-phenylalanine for detection of pancreatic cancer: basic investigations of the uptake characteristics in primary human pancreatic tumour cells and evaluation in in vivo models of human pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Drug Evaluation, Preclinical; Humans; Metabolic Clearance Rate; Mice; Mice, SCID; Organ Specificity; Pancreatic Neoplasms; Phenylalanine; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2004 |
Radioiodinated phenylalanine derivatives to image pancreatic cancer: a comparative study with [18F]fluoro-2-deoxy-D-glucose in human pancreatic carcinoma xenografts and in inflammation models.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Inflammation; Iodine Radioisotopes; Metabolic Clearance Rate; Mice; Mice, SCID; Organ Specificity; Pancreatic Neoplasms; Phenylalanine; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Transplantation, Heterologous | 2005 |
EGF receptor antagonism improves survival in a murine model of pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Animals; Cell Division; Cell Line, Tumor; Disease Models, Animal; ErbB Receptors; Erlotinib Hydrochloride; Gene Expression; Humans; Mice; Mice, Nude; Pancreatic Neoplasms; Phenylalanine; Protease Inhibitors; Protein Kinase Inhibitors; Quinazolines; Survival Rate; Thiophenes | 2006 |
Matrix metalloproteinase inhibition attenuates human pancreatic cancer growth in vitro and decreases mortality and tumorigenesis in vivo.
Topics: Animals; Humans; Metalloendopeptidases; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Pancreatic Neoplasms; Phenylalanine; Protease Inhibitors; Thiophenes; Tumor Cells, Cultured | 1997 |
Matrix metalloproteinase (MMP) inhibition selectively decreases type II MMP activity in a murine model of pancreatic cancer.
Topics: Adenocarcinoma; Animals; Blotting, Western; Collagenases; Gelatinases; Humans; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Metalloendopeptidases; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Pancreatic Neoplasms; Phenylalanine; Protease Inhibitors; Thiophenes; Tumor Cells, Cultured | 1999 |
Protein metabolism in glucagonoma.
Topics: Adult; Amino Acids; Blood Glucose; C-Peptide; Deuterium; Female; Glucagon; Glucagonoma; Humans; Infusions, Intravenous; Insulin; Leucine; Male; Middle Aged; Pancreatic Neoplasms; Phenylalanine; Protein Biosynthesis; Proteins; Reference Values; Tyrosine | 1999 |
Effects of angiogenesis inhibitors on multistage carcinogenesis in mice.
Topics: Angiostatins; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Carcinoma, Islet Cell; Collagen; Cyclohexanes; Disease Progression; Drug Evaluation, Preclinical; Endostatins; Female; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Staging; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Pancreatic Neoplasms; Peptide Fragments; Phenylalanine; Plasminogen; Sesquiterpenes; Thiophenes | 1999 |
Matrix metalloproteinase inhibition suppresses MMP-2 activity and activation of PANC-1 cells in vitro.
Topics: Animals; Dose-Response Relationship, Drug; Enzyme Activation; Gelatinases; Matrix Metalloproteinase 2; Matrix Metalloproteinases, Membrane-Associated; Metalloendopeptidases; Mice; Neoplasm Invasiveness; Osmolar Concentration; Pancreatic Neoplasms; Phenylalanine; Protease Inhibitors; Thiophenes; Tumor Cells, Cultured | 1999 |
Effect of matrix metalloproteinase inhibition on pancreatic cancer invasion and metastasis: an additive strategy for cancer control.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Humans; Liver Neoplasms, Experimental; Metalloendopeptidases; Mice; Mice, Nude; Neoplasm Invasiveness; Pancreatic Neoplasms; Phenylalanine; Thiophenes; Tumor Cells, Cultured | 2000 |
Addition of matrix metalloproteinase inhibition to conventional cytotoxic therapy reduces tumor implantation and prolongs survival in a murine model of human pancreatic cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Chromatography, Affinity; Deoxycytidine; Enzyme-Linked Immunosorbent Assay; Gemcitabine; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Pancreatic Neoplasms; Phenylalanine; Thiophenes; Time Factors; Tumor Cells, Cultured | 2000 |
Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration.
Topics: alpha-Amylases; Amino Acid Sequence; Animals; Cell Movement; Cell Size; Extracellular Matrix; Genes, Dominant; Humans; Hyaluronan Receptors; Leucine; Ligands; Matrix Metalloproteinase 14; Matrix Metalloproteinases, Membrane-Associated; Metalloendopeptidases; Mice; Molecular Sequence Data; Neoplasm Invasiveness; Pancreatic Neoplasms; Phenylalanine; Plant Proteins; Protein Processing, Post-Translational; Sequence Deletion; Solubility; Sulfones; Thiophenes; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Trypsin Inhibitors; Tumor Cells, Cultured | 2001 |
The diagnostic value of certain alkaline phosphatase isoenzyme patterns in human serum, fractions obtained by polyacrylamide disc electrophoresis.
Topics: ABO Blood-Group System; Adenocarcinoma; Alkaline Phosphatase; Electrophoresis, Disc; Evaluation Studies as Topic; Humans; Isoenzymes; Liver Neoplasms; Methods; Neoplasm Metastasis; Neuraminidase; Pancreatic Neoplasms; Phenylalanine; Stomach Neoplasms | 1975 |
Electrophoretic patterns of alkaline phosphatase isoenzymes in human sera with abnormally high activity, and an unusual band observed in sera of patients with pancreatic cancer.
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Adult; Aged; Alkaline Phosphatase; Electrophoresis, Cellulose Acetate; Female; Gastrointestinal Neoplasms; Homoarginine; Hot Temperature; Humans; Intestines; Isoenzymes; Liver; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Phenylalanine; Placenta | 1975 |
Inhibition by a nonmetabolized analogue of L-leucine of protein biosynthesis in tumoral pancreatic islet cells.
Topics: Adenoma, Islet Cell; Amino Acids; Amino Acids, Cyclic; Keto Acids; Leucine; Neoplasm Proteins; Pancreatic Neoplasms; Phenylalanine; Serine; Tumor Cells, Cultured | 1989 |
Pancreatic alkaline phosphatase and a tumour variant.
Topics: Adenocarcinoma; Adenoma, Islet Cell; Alkaline Phosphatase; Bone and Bones; Carcinoma; Electrophoresis, Disc; Histocytochemistry; Hot Temperature; Humans; Intestine, Small; Isoenzymes; Liver; Pancreas; Pancreatic Neoplasms; Phenylalanine; Urea | 1972 |
[The effect of thio-TEPA on the incorporation of labeled precursors into DNA and protein of human neoplastic cells in tissue culture].
Topics: Carbon Isotopes; Culture Techniques; DNA, Neoplasm; Female; Humans; Neoplasm Proteins; Ovarian Neoplasms; Pancreatic Neoplasms; Phenylalanine; Stomach Neoplasms; Thiotepa; Thymidine | 1968 |